Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Romain Clery"'
Autor:
Olivier Cussenot, Aurélien de Reyniès, Mira Ayadi, C. Gaffory, Geraldine Cancel-Tassin, Raphaëlle Renard-Penna, Romain Clery, Eva Comperat, V. Ondet, Ugo Pinar, Morgan Rouprêt
Publikováno v:
Journal of Urology. 206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2acfbc12cb2162ae2b8a738c79b41bc7
https://doi.org/10.1097/ju.0000000000002095.17
https://doi.org/10.1097/ju.0000000000002095.17
Autor:
Morgan Rouprêt, Pietro Grande, Igor Duquesne, Jonathan Olivier, Alain Ruffion, Jean Baptiste Beauval, Bertrand Guillonneau, Aurélien Gobert, Alexandre de la Taille, Romain Clery, Paul Lainé-Caroff, David Waltregny, Grégoire Robert, Daniele Panarello, Arnauld Villers, Thomas Seisen, Franck Bruyère, Thomas Prudhomme, Hubert De Bayser, Jean-Christophe Bernhard
Publikováno v:
World Journal of Urology. 37:1491-1498
Despite no consensus on the optimal management of recurrent prostate cancer after primary radiation or HIFU therapy, salvage prostatectomy (sRP) is reserved for only 3% of patients because of technical challenges and frequent post-operative complicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::941caaacfbf1e4909a3eb822856d7c9b
https://doi.org/10.1007/s00345-019-02683-0
https://doi.org/10.1007/s00345-019-02683-0
Publikováno v:
Salvage Therapy for Prostate Cancer ISBN: 9783030571801
According to the literature, approximately 50% of patients treated with first-line radiotherapy have biochemical recurrence at 10 years and it has been reported that up to 60% of patients will experience local recurrence (Agarwal PK, Sadetsky N, Kone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5603ffcd2475337757238fd0bee9d279
https://doi.org/10.1007/978-3-030-57181-8_3
https://doi.org/10.1007/978-3-030-57181-8_3
Autor:
Raphaëlle Renard-Penna, Morgan Rouprêt, O. Cussenot, Eva Compérat, Geraldine Cancel-Tassin, Mira Ayadi, C. Gaffory, A. De Reynies, V. Ondet, Romain Clery, Ugo Pinar
Publikováno v:
Progrès en Urologie. 30:775
Objectifs Le score pronostique de CAPRA est clinicobiologique et permet d’estimer le risque de recidive d’un cancer de prostate (CaP) apres traitement. Des recentes etudes preliminaires ont mis en evidence l’existence de sous-groupes moleculair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::481518b9d56fec6d507d3ea4445b80f1
https://doi.org/10.1016/j.purol.2020.07.139
https://doi.org/10.1016/j.purol.2020.07.139
Publikováno v:
Progrès en Urologie. 28:646-647
Objectifs Les traitements physiques de la prostate (radiotherapie, curietherapie ou hifu) sont parfois proposes en premiere ligne du traitement du cancer de la prostate (CAP). En cas de recidive biologique, certains patients jeunes se voient parfois
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04e31c8b3474cc6bb6efd7a66cd3755e
https://doi.org/10.1016/j.purol.2018.07.071
https://doi.org/10.1016/j.purol.2018.07.071